Michel Detheux Transaction History

Date Transaction Value Shares Traded Form
Jun 10 2025
SELL
Open market or private sale
$439,707 $10.02 p/Share
43,883
Jun 10 2025
BUY
Exercise of conversion of derivative security
$593,013 $4.3 p/Share
137,910
Jun 09 2025
SELL
Open market or private sale
$440,136 $10.03 p/Share
43,882
Jun 09 2025
BUY
Exercise of conversion of derivative security
$188,692 $4.3 p/Share
43,882
Jun 06 2025
SELL
Open market or private sale
$448,035 $10.21 p/Share
43,882
Jun 06 2025
BUY
Exercise of conversion of derivative security
$188,692 $4.3 p/Share
43,882
Jun 05 2025
SELL
Open market or private sale
$445,402 $10.15 p/Share
43,882
Jun 05 2025
BUY
Exercise of conversion of derivative security
$188,692 $4.3 p/Share
43,882
Jun 04 2025
SELL
Open market or private sale
$443,218 $10.1 p/Share
43,883
Jun 04 2025
BUY
Exercise of conversion of derivative security
$188,696 $4.3 p/Share
43,883

Also insider at

VOR
Vor Biopharma Inc. Healthcare
MD

Michel Detheux

Chief Executive Officer
Watertown, MA

Track Institutional and Insider Activities on ITOS

Follow iTeos Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ITOS shares.

Notify only if

Insider Trading

Get notified when an I Teos Therapeutics, Inc. insider buys or sells ITOS shares.

Notify only if

News

Receive news related to iTeos Therapeutics, Inc.

Track Activities on ITOS